-
A month after Roe reversal, demand for abortion pills remains high
Requests for abortion pills saw a 109 percent increase between June 24 and July 15, nonprofit organization Just the Pill told Becker's. -
COVID-19 vaccines and omicron: 2 new findings
As omicron subvariant BA.5 prompts a summer surge in COVID-19 cases, here are two recent studies on vaccine effectiveness against the quickly spreading variant: -
COVID-19 vaccines for children under 5: A state breakdown
The effort to vaccinate children younger than 5 has crawled since its infancy, with CDC data showing less than 3 percent of the nation's 19 million children in this age group with at least one vaccine jab. -
CVS prods prescriptions that can induce abortion
As physicians balance patient care in the turmoil following the Supreme Court's decision to reverse Roe v. Wade, the pharmaceutical industry has been hit on multiple fronts, and CVS Health is the latest retail chain to add another step in its pharmacy practices. -
White House prioritizes omicron-targeted vaccines over 2nd boosters
The Biden administration is pushing for vaccine-makers to tweak their vaccines for better efficacy against omicron subvariants BA.4 and BA.5 while suppressing efforts to deploy a second booster to adults younger than 50, The Washington Post reported July 22. -
The drug-pricing bill wading through Congress: 3 things to know
For months, legislators have chipped away at President Joe Biden's Build Back Better Act, with the resulting leftovers centering around lowering drug costs for Medicare and Medicaid beneficiaries, according to The Washington Post. -
1 month post-Roe, House passes Right to Contraception Act
About four weeks after the Supreme Court reversed the national right to an abortion, the House passed legislation July 21 to secure the right to contraceptives, according to CNBC. -
Staffing shortage could be hindering controversial Paxlovid clearance
When the FDA declared pharmacists could prescribe Pfizer's antiviral treatment directly to patients in early July, it caused a flurry of mixed reactions among the healthcare industry. The widespread staffing shortage could be halting the process, though. -
World's first malaria vaccine hits financing roadblock
As the World Health Organization continues its rollout of the first authorized malaria vaccine, one of the key investors has pulled out because of the vaccine's low efficacy, according to The Washington Post. -
Tracking each COVID-19 vaccine's journey
Now that Novavax has entered the COVID-19 vaccine scene, here's a rundown of the similarities and differences among each vaccine option, according to Yale Medicine: -
Novavax's COVID-19 vaccine fully authorized
After more than a year of Pfizer, Moderna and Johnson & Johnson shots going into people's arms, there's now a fourth vaccine option. -
Johnson & Johnson's general counsel to retire
The executive vice president and general counsel of Johnson & Johnson, Michael Ullman, MD, plans to retire by the end of 2022 and will be succeeded by Elizabeth Forminard, effective Oct. 17. -
10 hospitals seeking pharmacy leaders
The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week. -
#BoycottWalgreens trends after alleged birth control dispute
The hashtag "BoycottWalgreens" has flooded social media after a customer took to Twitter earlier this month, alleging a Walgreens worker refused to sell condoms because of religious reasons. -
FDA approves 1st at-home treatment for vitiligo
The FDA granted Incyte, a Wilmington, Del.-based pharmaceutical company, the first approval for a vitiligo treatment after finding positive results in its phase 3 trials July 18. -
Online pharmacy startup launches prescription subscriptions
An online pharmacy that isn't yet a year old introduced a new option for its customers July 18: Pay $10 a month for an unlimited number of prescriptions. -
Novavax approval won't boost vaccination rate, experts say
Though Novavax's COVID-19 vaccine candidate could appeal to those wary of mRNA-based vaccines, don't expect it to spur that much change, health experts told CNBC July 15. -
Despite federal guidance, pharmacists hesitant to fill some orders since Roe
Some pharmacists have been more cautious about filling prescriptions as legal concerns rise for healthcare workers offering reproductive care since the U.S. Supreme Court overturned Roe v. Wade, the Dallas Morning News reported July 18. -
COVID-19 shots for kids lag, prompting concern among health experts
As parents hesitate to inoculate their youngest children and some states are ordering fewer COVID-19 vaccine doses, health experts expressed worry about low vaccination rates, Politico reported July 14. -
Successful Migration to a Vancomycin AUC-dosing Protocol: Evaluation, Implementation and Outcomes in an Acute Care Hospital Setting
Vancomycin, an antibiotic medication used to treat serious bacterial infections, can lead to increased nephrotoxicity without improved efficacy if administered in an excessive dosage, or can fail to achieve the desired therapeutic effect if underdosed.
Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.